Latest Revenue Generation News

Enero Group’s half-year results reveal a 6.3% revenue decline but a striking 119% surge in adjusted profit, alongside strategic leadership changes and a steady dividend.

Robex Resources has officially reached commercial production at its Kiniero Gold Project in Guinea, marked by a significant first shipment of over 6,300 ounces of gold. This milestone sets the stage for the company’s strategic growth and upcoming merger plans.

AMP Limited's FY25 Data Pack highlights steady earnings with an underlying NPAT of $285 million, supported by strong Platforms net cashflows and a stable capital position. The report offers a detailed breakdown of business unit performance, costs, and market share.

Viva Leisure has reported a robust half-year performance with underlying NPAT up 46.8% and revenue climbing to $116.5 million, driven by strong organic membership growth and a booming technology segment.

Kaiser Reef has transformed the Union Hill waste dumps at its Maldon Gold Project into a significant low-grade gold stockpile, supporting profitable processing at Porcupine Flat through 2030. The company also announced new management appointments and ongoing exploration initiatives.

Rhythm Biosciences has taken a significant step toward commercialising its ColoSTAT blood test for colorectal cancer by enrolling the first physician in its Access Program, marking the transition from clinical trials to routine clinical use.

EVE Health Group has officially launched Libbo™, an oral dissolving film for erectile dysfunction, alongside a new digital platform aimed at improving men’s health access and education across Australia.

Memphasys Limited has secured Therapeutic Goods Administration approval for its Felix™ System two months ahead of schedule, enabling immediate commercial sales and clinical use in Australia.

Lotus Resources has launched a A$81 million equity raising to support the ramp-up of its Kayelekera uranium mine to steady state production targeted in Q2 2026, while advancing development of its Letlhakane project.

Cyclopharm Limited is accelerating its US market push for Technegas with a A$16 million capital raise following a record 2025 sales performance. The company aims to expand its US installations and advance new clinical applications beyond pulmonary embolism.

ION Video Ltd has strengthened its board with the return of its original inventor, Finbar O’Hanlon, alongside CEO Anthony Baker, as the company pivots to become foundational infrastructure for Video Superintelligence.

GCM Corporation is advancing its commercialisation strategy with multiple prototypes across key global markets and sectors, aiming for revenue in the first half of 2026.